Navigation Links
MINRAD Receives Notice That NYSE Alternext Intends to File Delisting Application With Securities and Exchange Commission
Date:2/6/2009

ORCHARD PARK, N.Y., Feb. 6 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (Amex: BUF) -- On February 2, 2009, the Company received a notice from NYSE Alternext US LLC (the "Exchange") stating that the Exchange intends to strike the common stock of the Company from the Exchange by filing a delisting application with the Securities and Exchange Commission pursuant to Section 1009(d) of the NYSE Alternext US Company Guide. By letter dated December 11, 2008, the Exchange had advised the Company that the Company was not in compliance with certain provision of the Exchange's Company Guide (the "Company Guide"), namely Section 1003(a)(i), with stockholders' equity of less than $2,000,000 and losses from continuing operations and net losses in two out of its three most recent fiscal years; 1003(a)(ii), with stockholders' equity of less than $4,000,000 and losses from continuing operations and net losses in three out of its four most recent fiscal years; 1003(a)(iii), with stockholders' equity of less than $6,000,000 and losses from continuing operations and net losses in its five most recent fiscal years; and 1003(a)(iv) in that it has sustained losses which are so substantial in relation to its overall operations or its existing financial resources, or its financial condition has become so impaired that it appears questionable, in the opinion of the Exchange, as to whether it will be able to continue operations and/or meet its obligations as they mature.

By letter dated December 26, 2008 the Company notified the staff it had entered into a definitive merger agreement with Piramal Healthcare, Inc., Piramal Healthcare Limited and Mayflower Acquisition Corp. for the acquisition of the Company and requested that the Exchange continue to list the Company's stock until consummation of that merger, at which time the Company would vo
'/>"/>

SOURCE MINRAD International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MINRAD International, Inc. Announces Reduction in Workforce
2. MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
3. MINRAD International, Inc. Announces $40.0 Million Private Placement
4. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
5. Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the Worlds First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
6. Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development
7. AdvanDx Receives FDA 510(k) Clearance for E. coli/P. aeruginosa PNA FISH(R)
8. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
9. Cell Therapeutics Receives Additional NASDAQ Notification
10. Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent
11. Victhom Human Bionics Neurobionix Division receives ISO 13485:2003 Certification for its Design Control System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... DALLAS , June 29, 2015 ... Type (DNA, RNA, XNA), by Application (Diagnostics, Therapeutics, R&D), by ... Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020", ... reach $244.93 Million by 2020 from $107.56 Million in 2015, ... market T ables and 67 F ...
(Date:6/29/2015)... Calif. , June 29, 2015   Veracyte, ... company pioneering the field of molecular cytology, today announced ... News Group,s prestigious Top Workplaces list for the second ... Workplace winners based solely on an annual survey of ... and honored that the degree to which Veracyte values ...
(Date:6/29/2015)... 29, 2015 Elsevier , ... products and services, today announced the highlights of its ... 2014 Journal Citation Reports® (JCR) published by Thomson Reuters, ... from 2013 to 2014, ahead of the aggregate across ... rank in 62 subject categories, up from 61 in ...
(Date:6/26/2015)... 26, 2015   Aratana Therapeutics, Inc ... therapeutics company focused on the licensing, development ... companion animals, today announced positive results from ... (AT-002), the company,s innovative therapeutic for appetite ... molecule that mimics ghrelin, the naturally occurring ...
Breaking Biology Technology:Aptamers Market Worth $244.93 Million by 2020 2Aptamers Market Worth $244.93 Million by 2020 3Aptamers Market Worth $244.93 Million by 2020 4Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5
... businesses will receive funding for technology development projects ... Technology Assistance Grant program. , ,The TAG program ... Wisconsin high-tech companies to offset the cost of ... are: Automated Notification Systems, Inc. , Eau ...
... They can cost as much as buildings and there ... the right people are involved and excited, said presenters at ... , ,"User ownership is absolutely essential," said Peter Strombom, CIO ... the application, if they don't feel they're being heard, you're ...
... - The nightmare of managing liability in identity ... of WTN Media's Digital Healthcare Conference, and healthcare providers ... it would be. , ,Using a hypothetical case of ... Michael Best & Friedrich demonstrated how much trouble ...
Cached Biology Technology:Healthcare leaders tell how they rally stakeholders around IT 2Managing the nightmare of identity theft 2Managing the nightmare of identity theft 3Managing the nightmare of identity theft 4
(Date:6/30/2015)... 30, 2015 Genisphere announced ... to help further develop Genisphere,s therapeutics capabilities and portfolio. ... having spent much of the last 25 years in ... Bioscience, and Johnson & Johnson. Tom started his career ... Biotech Corporate Finance. He graduated from Dartmouth College with ...
(Date:6/25/2015)... CITY , June 25, 2015  Imagine a ... steps toward a healthier, happier life. That,s exactly what ... designed to do. The cutting-edge, portable health program provides ... real-life solutions to help improve your lifestyle and nutrition. ... awards dinner and gala Wednesday night, USANA,s THA was ...
(Date:6/24/2015)... , June 24, 2015  Synaptics Inc. ... human interface solutions, today announced that Sharp has ... provide secure authentication for its latest flagship smartphone ... more than 200 million shipments of its fingerprint ... reinforces Synaptics, strength, scalability and leadership in the ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... Technology have developed a computer program that trains itself ... Fungi which range from yeast to mushrooms ... understanding the recently sequenced fungal genomes can help in ... help to identify potential targets for therapeutic intervention and ...
... out of a scrum herpes virus can cause a skin ... studied the spread of the disease among sumo wrestlers in Japan ... be even more pathogenic, according to an article published in the ... "Scrumpox", or herpes gladiatorum , is a skin infection ...
... has established a National Corrosion Center where researchers will ... that is estimated to cost $276 billion a year ... center, Rice is working closely with NACE International, an ... around the world who are involved in virtually every ...
Cached Biology News:Researchers develop new self-training gene prediction program for fungi 2Researchers develop new self-training gene prediction program for fungi 3Researchers develop new self-training gene prediction program for fungi 4Deadly rugby virus spreads in sumo wrestlers 2Rice University establishes National Corrosion Center 2
... formulated specifically for Alkaline Phosphatase conjugates. ... activity for both the enzyme and the ... This product has been chemically engineered ... a longer shelf life, resistance to various ...
... for arraying proteins of interest with ... equipment. DiscoverLight Protein Array Kits allow ... cell lysate or antibody in a ... specially designed nitrocellulose membranes with a ...
... formulated specifically for Alkaline Phosphatase conjugates. ... activity for both the enzyme and the ... This product has been chemically engineered ... a longer shelf life, resistance to various ...
Request Info...
Biology Products: